Skip to main content
Home
About Us
Market
Management
Management
Board of Directors
Pipeline
Investor Relations
News
Stock Information
Stock Quote
Historical Stock Quote
Investment Calculator
SEC Filings
Corporate Governance
Governance Documents
Board of Directors
Shareholder Services
Investor FAQs
Investor Emails Alerts
Investor Contact
Contact Us
Site Search
Pipeline
Home
About Us
Market
Management
Management
Board of Directors
Pipeline
Investor Relations
News
Stock Information
Stock Quote
Historical Stock Quote
Investment Calculator
SEC Filings
Corporate Governance
Governance Documents
Board of Directors
Shareholder Services
Investor FAQs
Investor Emails Alerts
Investor Contact
Contact Us
FB-102
CD122 is subunit of IL-2/IL-15 receptors which are key regulators of NK cells and T cell subsets
FB-102 (Forte’s anti-CD122 antibody) is designed to mediate NK and CD 8+ T cells specifically
Significant amount of proof-of-concept preclinical data supports activity of CD-122 blockade, including in GvHD and vitiligo